AMAG Pharmaceuticals Inc (NASDAQ:AMAG)
During the Trading Day
| 17.94 |  -0.50 / -2.71% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 17.96 |  +0.0182 / +0.10% |
Volume: 800.00 |
Latest AMAG News | Press Releases
Today’s Trading
| Previous close | 18.44 |
| Today’s open | 18.54 |
| Day’s range | 17.82 - 18.57 |
| Volume | 280,994 |
| Average volume (3 months) | 343,322 |
| Market cap | $404.1M |
| Dividend yield | -- |
Data as of 4:00pm ET, 07/28/2014
Growth & Valuation
| Earnings growth (last year) | +43.59% |
| Earnings growth (this year) | -3.79% |
| Earnings growth (next 5 years) | +35.00% |
| Revenue growth (last year) | -5.30% |
| P/E ratio | NM |
| Price/Sales | 6.52 |
| Price/Book | 2.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GERNGeron Corp | -0.03 | -1.24% |
| DNDNDendreon Corp | -0.05 | -2.34% |
| GALTGalectin Therapeutic... | -0.78 | -5.09% |
| VCYTVeracyte Inc | +0.01 | +0.07% |
Data as of 4:00pm ET, 07/28/2014
Financials
| Next reporting date | July 30, 2014 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $80.9M |
| Annual profit (last year) | -$9.6M |
| Net profit margin | -11.88% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director William K. Heiden |
Chief Operating Officer & Executive Vice President Frank E. Thomas |
Corporate headquarters Lexington, Massachusetts |
Forecasts
.
